As women navigate the changes of midlife and menopause, maintaining cognitive vitality often becomes a focus. Lion’s mane mushroom (Hericium erinaceus) has garnered attention for its potential role in supporting brain health, with much of this interest revolving around its unique compounds and their interaction with nerve growth factor (NGF).
This article will explore the current understanding of how lion’s mane may influence NGF and what this could mean for brain function, offering an evidence-based perspective for those seeking to understand its potential benefits.
Understanding Nerve Growth Factor (NGF)
Nerve Growth Factor (NGF) is a crucial protein that plays a significant role in the growth, maintenance, proliferation, and survival of nerve cells, including those in the brain. It is essential for the health and function of neurons, which are the fundamental building blocks of our nervous system. Adequate NGF levels are important for cognitive processes, including learning and memory.
Research into compounds that can influence NGF levels or activity is ongoing, particularly for their potential to support neurological health. The delicate balance of NGF production and function is vital for maintaining robust brain function throughout life.
Lion’s Mane and its Unique Compounds
Lion’s mane mushroom contains a variety of bioactive compounds, with two categories, hericenones and erinacines, being particularly noted for their potential neurotrophic properties. Hericenones are found primarily in the fruiting body of the mushroom [1][2], while erinacines are typically isolated from the mycelium [3][4].
These compounds have been the subject of various studies exploring their biological activities. The interest in lion’s mane stems from its potential to interact with pathways related to brain health, including its possible influence on NGF [5][6].
How Lion’s Mane May Influence NGF
Several studies have investigated the potential of lion’s mane to induce or support NGF activity. For instance, research has shown that compounds from Hericium erinaceus can demonstrate NGF-mediated neurite outgrowth in PC12 cells via MEK/ERK and PI3K-Akt signaling pathways [1]. This suggests a mechanism by which lion’s mane compounds might encourage the growth and differentiation of nerve cells.
Further studies have indicated nerve growth factor-inducing activity of Hericium erinaceus in human astrocytoma cells [7]. Neurotrophic isoindolinones, a type of erinacine, have also been identified from the fruiting bodies of Hericium erinaceus, contributing to the understanding of its potential neurotrophic effects [4]. These findings collectively point towards the mushroom’s potential to support NGF-related processes in cellular models.
The overall neurotrophic and neuroprotective effects of Hericium erinaceus are a focus of ongoing research, with its potential to stimulate NGF production being a key area of interest for supporting brain health [6][5].
Lion’s Mane and Cognitive Support
Beyond its direct influence on NGF in cellular models, the potential impact of lion’s mane on cognitive function has also been explored. Some research suggests that lion’s mane mycelium and its isolated compound, erinacine A, may help ameliorate spatial learning deficits in aging mice that were fed a high-fat, high-sucrose diet [3]. This indicates a possible role in supporting aspects of cognitive function.
The broader ‘brain health triad’ concept, which includes neurostimulating, neurotrophic, and neuroprotective synergies, is an area where lion’s mane’s phytochemical and fungal bioactive compounds are being considered [8]. This holistic view suggests that lion’s mane may contribute to overall brain resilience. While more human studies are needed, the preliminary evidence from various models offers an intriguing picture of its potential to support brain health during midlife and menopause.
Other Potential Areas of Research
While the focus on NGF is strong, lion’s mane is also being explored for other potential benefits related to neurological and mood support. For example, some research has looked into its potential to reduce symptoms of depression and anxiety after four weeks of intake [9].
Additionally, the biotransformation of Hericium erinaceus is being investigated for its potential to modulate the gut-brain axis and influence mood-related outcomes in humans, possibly through CREB/BDNF signaling and microbiota-driven synergies [10]. These areas highlight the multifaceted nature of lion’s mane research and its potential beyond direct NGF induction, though more comprehensive human studies are required to draw firm conclusions.
References
- Hericium erinaceus (Bull.: Fr) Pers. cultivated under tropical conditions: isolation of hericenones and demonstration of NGF-mediated neurite outgrowth in PC12 cells via MEK/ERK and PI3K-Akt signaling pathways. Food & function, 2014
- Uncovering Hericenones from the Fruiting Bodies of Hericium erinaceus through Interdisciplinary Collaboration. Journal of natural products, 2025
- Hericium erinaceus Mycelium and Its Isolated Compound, Erinacine A, Ameliorate High-Fat High-Sucrose Diet-Induced Metabolic Dysfunction and Spatial Learning Deficits in Aging Mice. Journal of medicinal food, 2019
- Neurotrophic isoindolinones from the fruiting bodies of Hericium erinaceus. Bioorganic & medicinal chemistry letters, 2021
- Lion’s Mane Mushroom (Hericium erinaceus): A Neuroprotective Fungus with Antioxidant, Anti-Inflammatory, and Antimicrobial Potential-A Narrative Review. Nutrients, 2025
- Neurotrophic and Neuroprotective Effects of Hericium erinaceus. International journal of molecular sciences, 2023
- Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biological & pharmaceutical bulletin, 2008
- Phytochemical and Fungal Bioactive Compounds in the “Brain Health Triad”: A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. International journal of molecular sciences, 2026
- Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical research (Tokyo, Japan), 2010
- Biotransformation of Ganoderma lucidum and Hericium erinaceus for ex vivo gut-brain axis modulation and mood-related outcomes in humans: CREB/BDNF signaling and microbiota-driven synergies. Journal of ethnopharmacology, 2025
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.